依赖于JAK3/STAT5A的IL-8调节驱动ESCC血管生成,并被二甲米西宁抑制
Kai Zhang1, Xiaoshuo Dai1, Wei Chen1
1Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan Province 450001, PR China.
International immunopharmacology
|June 12, 2025
概括
乙甲胺素 (DHA) 向JAK3/STAT5A/IL-8通路,以抑制食道状细胞癌 (ESCC) 血管生成. 这项研究为ESCC抗血管生成疗法提供了一个新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 瘤微环境显著影响瘤血管生成.
- 在食道状细胞癌 (ESCC) 中促进血管生成的机制需要进一步阐明.
研究的目的:
- 研究ESCC诱导的血管生成背后的分子机制.
- 评估二甲胺素 (DHA) 在向ESCC血管生成方面的治疗潜力.
主要方法:
- 用ESCC细胞超剂治疗的HUVECs的转录组分析.
- 研究了JAK3/STAT5A通路和IL-8的作用.
- 在体外和体内评估了DHA对血管生成的抑制作用.
主要成果:
- 通过JAK3 / STAT5A通路调解的ESCC超水体在HUVEC中显著上调节IL-8.
- 准JAK3有效抑制了ESCC血管生成.
- DHA直接抑制了JAK3,抑制了体外和体内血管生成,并通过JAK3/STAT5A/IL-8信号通路起作用.
结论:
- JAK3/STAT5A/IL-8通路对于调节ESCC血管生成至关重要.
- DHA证明了作为一种JAK3抑制剂的有效性,用于抗ESCC血管生成疗法.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K


